A (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione DMF (Drug Master File) is a document detailing the whole manufacturing process of (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione active pharmaceutical ingredient (API) in detail. Different forms of (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione DMFs exist exist since differing nations have different regulations, such as (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione DMF submitted to regulatory agencies in the US is known as a USDMF. (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione USDMF includes data on (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of (E)-8-(3,4-Dimethoxystyryl)-1,3-diethyl-7-methyl-1H-purine-2,6(3H,7H)-dione suppliers with USDMF on PharmaCompass.